Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trial

American Journal of Kidney Diseases

Volumn 27, Issue 4, 1996, Pages 489-495

  Ihle, B U ^a   Whitworth, J A ^a   Shahinfar, S ^a   Cnaan, A ^a   Kincaid Smith, P S ^a   Becker, G J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Enalapril; mixed effects linear model; nondiabetic; renal protection; severe renal impairment

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

EID: 0029980377     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90158-4     Document Type: Article

References (0)